| Date Filed | Type | Description |
| 09/29/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/24/2023 |
4
| BERMAN RICHARD J (Director) has filed a Form 4 on BIOVIE INC.|
Txns:
| Sold 10,805 shares
@ $3.5009, valued at
$37.8k
|
|
| 08/18/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/16/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| DO CUONG V (CEO & President) has filed a Form 4 on BIOVIE INC.|
Txns:
| Granted 149,500 shares
@ $0
Granted 175,000 options to buy
@ $4.0953, valued at
$716.7k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| BERMAN RICHARD J (Director) has filed a Form 4 on BIOVIE INC.|
Txns:
| Sold 5,000 shares
@ $6.5012, valued at
$32.5k
Sold 5,984 shares
@ $5.8125, valued at
$34.8k
|
|
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/31/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 03/13/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 03/10/2023 |
SC 13D/A
| Acuitas Group Holdings, LLC reports a 72.1% stake in BIOVIE INC. |
| 03/07/2023 |
SC 13D/A
| Acuitas Group Holdings, LLC reports a 87% stake in BIOVIE INC. |
| 03/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| DO CUONG V (CEO & President) has filed a Form 4 on BIOVIE INC.|
Txns:
| Paid exercise price by delivering 4,953 shares
@ $6.12, valued at
$30.3k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| READING CHRISTOPHER (EVP Neuroscience R&D) has filed a Form 4 on BIOVIE INC.|
Txns:
| Paid exercise price by delivering 2,476 shares
@ $6.12, valued at
$15.2k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|